Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study†
Roberta Zangaglia MD
Parkinson's Disease and Movement Disorders Unit, IRCCS “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Search for more papers by this authorClaudio Pacchetti MD
Parkinson's Disease and Movement Disorders Unit, IRCCS “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Search for more papers by this authorChiara Pasotti MD
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Laboratory of Neuropsychology, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Search for more papers by this authorFrancesca Mancini MD
Unit of Neurology, San Pio X Institute, Milan, Italy
Search for more papers by this authorDomenico Servello MD
Unit of Functional Neurosurgery, IRCCS Galeazzi Insitute, Milan, Italy
Search for more papers by this authorCorresponding Author
Elena Sinforiani MD
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Laboratory of Neuropsychology, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Laboratory of Neuropsychology, IRCCS C. Mondino, via Mondino 2, 27100 Pavia, ItalySearch for more papers by this authorSilvano Cristina MD
Parkinson's Disease and Movement Disorders Unit, IRCCS “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Search for more papers by this authorMarco Sassi MD
Unit of Functional Neurosurgery, IRCCS Galeazzi Insitute, Milan, Italy
Search for more papers by this authorGiuseppe Nappi MD
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Chair of Neurology, University “La Sapienza”, Rome, Italy
Search for more papers by this authorRoberta Zangaglia MD
Parkinson's Disease and Movement Disorders Unit, IRCCS “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Search for more papers by this authorClaudio Pacchetti MD
Parkinson's Disease and Movement Disorders Unit, IRCCS “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Search for more papers by this authorChiara Pasotti MD
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Laboratory of Neuropsychology, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Search for more papers by this authorFrancesca Mancini MD
Unit of Neurology, San Pio X Institute, Milan, Italy
Search for more papers by this authorDomenico Servello MD
Unit of Functional Neurosurgery, IRCCS Galeazzi Insitute, Milan, Italy
Search for more papers by this authorCorresponding Author
Elena Sinforiani MD
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Laboratory of Neuropsychology, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Laboratory of Neuropsychology, IRCCS C. Mondino, via Mondino 2, 27100 Pavia, ItalySearch for more papers by this authorSilvano Cristina MD
Parkinson's Disease and Movement Disorders Unit, IRCCS “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Search for more papers by this authorMarco Sassi MD
Unit of Functional Neurosurgery, IRCCS Galeazzi Insitute, Milan, Italy
Search for more papers by this authorGiuseppe Nappi MD
Interdepartmental Research Center for Parkinson's Disease, “C. Mondino Institute of Neurology” Foundation, Pavia, Italy
Chair of Neurology, University “La Sapienza”, Rome, Italy
Search for more papers by this authorPotential conflict of interest: None reported.
Abstract
There is debate over the cognitive and behavioral effects of deep brain stimulation (DBS) of the subthalamic nucleus (STN) in advanced Parkinson's disease (PD). To evaluate these effects, we performed a prospective, naturalistic controlled, 3-year follow-up study. A total of 65 PD patients were enrolled, of whom 32 underwent STN-DBS (PD-DBS) and 33, even though eligible for this treatment, declined surgery and chose other therapeutic procedures (PD-control). Motor and neuropsychological functions were assessed in all the subjects at baseline (T0) and 36 months (T36). The PD-DBS patients were also evaluated at 1, 6, 12, and 24 months after surgery (T1, T6, T12, and T24). At T1, compared with T0, the PD-DBS patients recorded worse logical executive function task and verbal fluency (FAS) scores, whereas their performance of memory tasks remained stable. At T12, their cognitive profile had returned within the pre-DBS range, thereafter remaining stable until T36. FAS scores at T36 were significantly worse in the PD-DBS compared with the PD-control patients. This is the first long-term naturalistic controlled study of cognitive functions in PD patients submitted to STN-DBS. Our results confirm previous reports of a worsening of verbal fluency after DBS, but show that STN-DBS seems to be relatively safe from a cognitive standpoint, as the short-term worsening of frontal-executive functions was found to be transient. © 2009 Movement Disorder Society
REFERENCES
- 1 Seijo FJ,Alvarez-Vega MA,Gutierrez JC,Fdez-Glez F,Lozano B. Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson's disease. Review of 272 procedures. Acta Neurochir (Wien) 2007; 149: 867–875; discussion 876.
- 2 Krack P,Batir A,van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925–1934.
- 3 Kenney C,Simpson R,Hunter C,Ondo W,Almaguer M,Davidson A,Jankovic J. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 2007; 106: 621–625.
- 4 Rodriguez-Oroz MC,Obeso JA,Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005; 128 (Pt 10): 2240–2249.
- 5 Rodriguez-Oroz MC,Zamarbide I,Guridi J,Palmero MR,Obeso JA. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry 2004; 75: 1382–1385.
- 6 Klepac N,Trkulja V,Relja M,Babić T. Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study. Eur J Neurol 2008; 15: 128–133.
- 7 Morrison CE,Borod JC,Perrine K, et al. Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease. Arch Clin Neuropsychol 2004; 19: 165–181.
- 8 Smeding HM,Speelman JD,Koning-Haanstra M,Schuurman PR,Nijssen P,van Laar T,Schmand B. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 2006; 66: 1830–1836.
- 9 York MK,Dulay M,Macias A,Levin H,Grossman R,Simpson R,Jankovic J. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 79: 789–795.
- 10 Witt K,Daniels C,Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605–614.
- 11 Alegret M,Junqué C,Valldeoriola F,Vendrell P,Pilleri M,Rumià J,Tolosa E. Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch Neurol 2001; 58: 1223–1227; Comments in: Arch Neurol 2001;58: 1205–1206.
- 12 Ardouin C,Pillon B,Peiffer E, et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999; 46: 217–223.
- 13 De Gaspari D,Siri C,Di Gioia M, et al. Clinical correlates and cognitive underpinnings of verbal fluency impairment after chronic subthalamic stimulation in Parkinson's disease. Parkinsonism Relat Disord 2006; 12: 289–295
- 14 Funkiewiez A,Ardouin C,Caputo E, et al. Long-term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 834–839.
- 15 Aybek S,Gronchi-Perrin A,Berney A,Chiuvé SC,Villemure JG,Burkhard PR,Vingerhoets FJ. Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease. Mov Disord 2007; 22: 974–981.
- 16 Schupbach WM,Chastan N,Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 years follow up. J Neurol Neurosurg Psychiatry 2005; 76: 1640–1644.
- 17 Contarino MF,Daniele A,Sibilia AH,Romito LMA,Bentivoglio AR,Gainotti G,Albanese A. Cognitive outcome five years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 248–252.
- 18 Langston JW,Windner H,Goetz CG, et al. Core assessement program for intracerebral transplantation (CAPIT). Mov Disord 1992; 7: 2–13.
- 19 Gibb WR,Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's Disease. J Neurol Neurosurg Psychiatry 1988; 51: 745–752.
- 20 Fahn S,Elton RL, members of the UPDRS Development Committee. The Unified Parkinson's Disease Rating scale. In: S Fahn, CD Marsden, DB Calne, M Goldstein, editors. Recent developments in Parkinson's disease, Vol. 2. Florham Park, NJ: Macmillan Healthcare Information; 1987. p 153–163, 293–304.
- 21 Hoehn MM,Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–432.
- 22 Folstein MF,Folstein SE,McHugh PR. Mini Mental State: a practical method grading the cognitive status of patients for the clinicians. J Psychiatry Res 1975; 12: 189–198.
- 23 Laiacona M,Indaghi MG,De Tanti A,Capitani E. Wisconsin Card Sorting Test: a new global score, with Italian norms, and its relationship with the Weigl Sorting Test. Neurol Sci 2000; 21: 279–291.
- 24 Spinnler H,Tognoni G. Taratura e standardizzazione italiana di test neuropsicologici. Ital J Neurol Sci 1987; 7( Suppl 8): 1–120.
- 25 Carlesimo CA,Caltagirone C,Gainotti G,Nocentini U. Batteria per la valutazione del deterioramento mentale: standardizzazione e affidabilità diagnostica nell'identificazione di pazienti affetti da sindrome demenziale. Archivio di Psicologia. Neurologia e Psichiatria 1995; 56: 471–488.
- 26 Appleby BS,Duggan PS,Regenberg A,Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov Disord 2007; 22: 1722–1728.
- 27 Witt K,Pulkowski U,Herzog J, et al. Deep brain stimulation of the subthalamic nucleus improves cognitive flexibility but impairs response inhibition in Parkinson's disease. Arch Neurol 2004; 61: 697–700.
- 28 Ory-Magne F,Brefel-Courbon C,Simonetta-Moreau M, et al. Does ageing influence deep brain stimulation outcomes in Parkinson's disease? Mov Disord 2007; 22: 1457–1463.
- 29 Gironell A,Kulisevsky J,Rami L,Fortuny N,García-Sánchez C,Pascual-Sedano B. Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease. A controlled comparative study. J Neurol 2003; 250: 917–923.
- 30 Saint-Cyr JA,Trépanier LL,Kumar R,Lozano AM,Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000; 123(Pt 10): 2091–2108.
- 31 Moretti R,Torre P,Antonello RM, et al. Neuropsychological changes after subthalamic nucleus stimulation: a 12 month follow-up in nine patients with Parkinson's disease. Parkinsonism Relat Disord 2003; 10: 73–79.
- 32 Troster AI,Woods SP,Fields JA. Verbal fluency declines after pallidotomy: an interaction between task and lesion laterality. Appl Neuropsychol 2003; 10: 69–75.
- 33 Alegret M,Valldeoriola F,Marti M, et al. Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease. Mov Disord 2004; 19: 1463–1469.
- 34 Wojtecki L,Timmermann L,Jörgens S, et al. Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation. Arch Neurol 2006; 63: 1273–1276.
- 35 Kempster PA,Williams DR,Selikhova M,Holton J,Revesz T,Lees AJ. Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain 2007; 130(Pt 8): 2123–2128.